You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨新鋭醫藥(6108.HK)六日累漲236% 去年收益增加151.8% 二代頭孢產品放量
格隆匯 04-12 10:19
格隆匯4月12日丨新鋭醫藥(6108.HK)大漲近19%,報0.41港元,近六日累漲236%,總市值7億港元。新鋭醫藥此前公佈,截至2021年12月31日止年度,公司錄得收益約3.35億港元,較2020年增加約151.8%;公司擁有人應占淨虧損約為280萬港元,較2020年減少約96.0%。於2021年12月31日,集團資產負債比率約為1.8%。公司稱,二代頭孢產品銷量增長是收入大增的主因,同時,減值虧損顯著降低也成為盈利減虧的重要因素。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account